Clinical Trial Update: Preclinical Safety Evaluation and First-in-Human Translational Study of [177Lu]Lu-TEFAPI-06 [EARLY_Phase 1]

View source ↗

Summary

This update reports preclinical safety evaluation and the first-in-human translational study of [177Lu]Lu-TEFAPI-06 for metastatic solid tumors, in an EARLY Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• [177Lu]Lu-TEFAPI-06 (TEFAPI-06 radiopharmaceutical labeled with Lutetium-177)

Snippet

Sponsor: Lanzhou University Second Hospital | Conditions: Metastatic Solid Tumors (Any Localization) | EARLY_Phase 1 | Status: COMPLETED